About Us

DotBio’s proprietary DotBody technology platform is based on the concept of modular design. By prefabricating antibody modules with specific functions, DotBio is able to combine them on demand to build multi-functional antibodies. This high throughput process allows DotBio to generate bi- and tri-specific antibodies, antibody-drug conjugates (ADCs) and intracellular antibodies in a matter of months.

Partners and shareholders